STOCK TITAN

CareDx to Report First Quarter 2025 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

CareDx (Nasdaq: CDNA), a company specializing in transplant healthcare solutions, has announced it will release its first quarter 2025 financial results after market close on Wednesday, April 30, 2025. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results.

Interested participants can join the call by dialing 1-800-445-7795 (domestic) or 1-785-424-1699 (international) with Conference ID: CareDx. A webcast will be available in the Events & Presentations section of CareDx's Investor Relations website.

CareDx (Nasdaq: CDNA), un'azienda specializzata in soluzioni per la salute dei trapianti, ha annunciato che rilascerà i suoi risultati finanziari del primo trimestre 2025 dopo la chiusura del mercato mercoledì 30 aprile 2025. L'azienda ospiterà una conferenza telefonica alle 13:30 ora del Pacifico / 16:30 ora dell'Est per discutere i risultati.

I partecipanti interessati possono unirsi alla chiamata componendo il numero 1-800-445-7795 (nazionale) o 1-785-424-1699 (internazionale) con l'ID Conferenza: CareDx. Un webcast sarà disponibile nella sezione Eventi e Presentazioni del sito web delle Relazioni con gli Investitori di CareDx.

CareDx (Nasdaq: CDNA), una empresa especializada en soluciones de salud para trasplantes, ha anunciado que publicará sus resultados financieros del primer trimestre de 2025 después del cierre del mercado el miércoles 30 de abril de 2025. La empresa llevará a cabo una llamada de conferencia a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este para discutir los resultados.

Los participantes interesados pueden unirse a la llamada marcando el 1-800-445-7795 (nacional) o el 1-785-424-1699 (internacional) con el ID de Conferencia: CareDx. Se dispondrá de un webcast en la sección de Eventos y Presentaciones del sitio web de Relaciones con Inversores de CareDx.

CareDx (Nasdaq: CDNA), 이식 건강 관리 솔루션 전문 기업이 2025년 1분기 재무 결과를 2025년 4월 30일 수요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 결과를 논의하기 위해 태평양 표준시 기준 오후 1시 30분 / 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 개최합니다.

관심 있는 참가자는 1-800-445-7795 (국내) 또는 1-785-424-1699 (국제)로 전화하여 회의 ID: CareDx로 콜에 참여할 수 있습니다. CareDx의 투자자 관계 웹사이트의 이벤트 및 프레젠테이션 섹션에서 웹캐스트가 제공됩니다.

CareDx (Nasdaq: CDNA), une entreprise spécialisée dans les solutions de santé pour les transplantations, a annoncé qu'elle publiera ses résultats financiers du premier trimestre 2025 après la fermeture du marché, le mercredi 30 avril 2025. L'entreprise organisera une conférence téléphonique à 13h30 heure du Pacifique / 16h30 heure de l'Est pour discuter des résultats.

Les participants intéressés peuvent rejoindre l'appel en composant le 1-800-445-7795 (national) ou le 1-785-424-1699 (international) avec l'ID de conférence : CareDx. Un webinaire sera disponible dans la section Événements et Présentations du site Web des Relations avec les Investisseurs de CareDx.

CareDx (Nasdaq: CDNA), ein Unternehmen, das sich auf Transplantationsgesundheitslösungen spezialisiert hat, hat angekündigt, dass es seine Finanzergebnisse für das erste Quartal 2025 nach Marktschluss am Mittwoch, den 30. April 2025, veröffentlichen wird. Das Unternehmen wird um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.

Interessierte Teilnehmer können sich unter 1-800-445-7795 (national) oder 1-785-424-1699 (international) mit der Konferenz-ID: CareDx in die Konferenz einwählen. Ein Webcast wird im Bereich Veranstaltungen und Präsentationen der Investor Relations-Website von CareDx verfügbar sein.

Positive
  • None.
Negative
  • None.

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the first quarter 2025 after market close on Wednesday, April 30, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 1-800-445-7795 for domestic callers or 1-785-424-1699 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CareDx, Inc.

Investor Relations

Caroline Corner

investor@caredx.com

Source: CareDx, Inc.

FAQ

When will CareDx (CDNA) release its Q1 2025 earnings?

CareDx will release its Q1 2025 earnings after market close on Wednesday, April 30, 2025.

How can investors join CareDx's Q1 2025 earnings call?

Investors can dial 1-800-445-7795 (domestic) or 1-785-424-1699 (international) with Conference ID: CareDx.

What time is CareDx's Q1 2025 earnings conference call?

The conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on April 30, 2025.

Where can I find CareDx's Q1 2025 earnings webcast?

The webcast will be available in the Events & Presentations section of CareDx's Investor Relations website at investors.caredx.com.
Caredx

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Stock Data

997.11M
53.18M
3.37%
94.9%
9.34%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BRISBANE